Skip to main content
SpringerLink
Log in

What is new in the management of Helicobacter pylori?

  • Review Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Since the discovery of Helicobacter pylori in the early 1980s several treatment regimens have been developed to effectively treat this infection. International guidelines have allowed consensus on the best management and improved eradication rates. In recent years increasing antimicrobial resistance and falling eradication rates highlight the need for updated guidelines. In this article we review the most recent European management guidelines and in view of the unavailability of some drugs consider new treatment regimens for the management of H. pylori in Ireland.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Marshall BJ, Warren JR (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1(8336):1273–1275

    Google Scholar 

  2. Coghlan JG, Gilligan D, Humphries H et al (1987) Campylobacter pylori and recurrence of duodenal ulcers—a 12-month follow-up study. Lancet 2(8568):1109–1111

    Article  PubMed  CAS  Google Scholar 

  3. Malfertheiner P, Megraud F, O’Morain C et al (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 56(6):772–781

    Article  PubMed  CAS  Google Scholar 

  4. Lee JM, Deasy E, O’Morain CA (2000) Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice. Eur J Gastroenterol Hepatol 12(4):433–437

    Article  PubMed  CAS  Google Scholar 

  5. Chiba N, Veldhuyzen Van Zanten SJO et al (2002) Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 324(7344):1012–1016

    Article  PubMed  CAS  Google Scholar 

  6. Franchini M, Veneri D (2004) Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter 9:342–346

    Article  PubMed  Google Scholar 

  7. Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359:14–22

    Article  PubMed  CAS  Google Scholar 

  8. Gisbert JP, Pajares JM (2004) Review article: C-urea breath test in the diagnosis of Helicobacter pylori infection—a critical review. Aliment Pharmacol Ther 20:1001–1017

    Article  PubMed  CAS  Google Scholar 

  9. Rogge JD, Wagner DR, Carrico RJ et al (1995) Evaluation of a new urease reagent strip for detection of Helicobacter pylori in gastric biopsy specimens. Am J Gastroenterol 90:1965–1968

    PubMed  CAS  Google Scholar 

  10. Egan BJ, Ryan BM, O’Morain CA Test, treat and confirm eradication. BMJ online 13/2/07

  11. Saleem A, Dobson M, Thornton O, O’Connor HJ, O’Morain CA ISG. Poster presentation 2006

  12. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 52(24):6735–6740

    PubMed  CAS  Google Scholar 

  13. Cheung TK, Wong BC (2008) Treatment of Helicobacter pylori and prevention of gastric cancer. J Dig Dis 9(1):8–13

    Article  PubMed  Google Scholar 

  14. Laheij R (2006) Is community treatment of H. pylori feasible?. United European Gastroenterology Week, Berlin

    Google Scholar 

  15. Fischbach L, Evans EL (2007) Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 26(3):343–357

    PubMed  CAS  Google Scholar 

  16. Hooton C, Dempsey C, Keohane J et al (2006) Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates. Br J Biomed Sci 63(3):113–116

    Article  PubMed  CAS  Google Scholar 

  17. Ford A, Moayyedi P (2003) How can the current strategies for Helicobacter pylori eradication therapy be improved? Can J Gastroenterol 17(Suppl B):36B–40B

    PubMed  Google Scholar 

  18. Egan BJ, Katicic M, O’Connor HJ, O’Morain CA (2007) Treatment of Helicobacter pylori. Helicobacter 12(Suppl 1):31–37

    Article  PubMed  CAS  Google Scholar 

  19. Lesbros-Pantoflickova D, Corthésy-Theulaz I, Blum AL (2007) Helicobacter pylori and probiotics. J Nutr 137(3 Suppl 2):812S–818S

    PubMed  CAS  Google Scholar 

  20. De Bortoli N, Leonardi G, Ciancia E et al (2007) Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 102(5):951–956

    Article  PubMed  CAS  Google Scholar 

  21. Cremonini F, Di Caro S, Covino M et al (2002) Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97(11):2744–2749

    Article  PubMed  Google Scholar 

  22. Uygun A, Ozel AM, Yildiz O et al (2008) J Gastroenterol Hepatol. Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy. J Gastroenterol Hepatol 23(1):42–45

    Article  PubMed  CAS  Google Scholar 

  23. Gisbert JP, De la Morena F (2006) Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 23(1):35–44

    Article  PubMed  CAS  Google Scholar 

  24. Gisbert JP, Bermejo F, Castro-Fernández M et al (2008) H. pylori study group of the Asociación Española de Gastroenterología. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. Am J Gastroenterol 103(1):71–76

    PubMed  CAS  Google Scholar 

  25. Van der Poorten D, Katelaris PH (2007) The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice. Aliment Pharmacol Ther 26(11–12):1537–1542

    PubMed  Google Scholar 

  26. Miehlke S, Schneider-Brachert W, Kirsch C et al (2008) One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 13(1):69–74

    PubMed  CAS  Google Scholar 

  27. Gisbert JP, Gisbert JL, Marcos S et al (2008) Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther 27(4):346–354

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, Adelaide and Meath Hospital incorporating the National Children’s Hospital Tallaght, Trinity College Dublin, Tallaght, Dublin, Ireland

    B. J. Egan, H. J. O’Connor & C. A. O’Morain

Authors
  1. B. J. Egan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. J. O’Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. A. O’Morain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. J. Egan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Egan, B.J., O’Connor, H.J. & O’Morain, C.A. What is new in the management of Helicobacter pylori?. Ir J Med Sci 177, 185–188 (2008). https://doi.org/10.1007/s11845-008-0173-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-008-0173-8

Keywords

Search

Navigation